Nilepath offers a SaaS platform that aggregates anonymized, high‑resolution pathology slide images into a global data hub and provides AI‑assisted annotation tools for creating labeled datasets. By partnering with low‑resource labs, it delivers subsidized diagnostic testing while generating high‑quality imaging data, which can be licensed through a secure marketplace to AI developers for training and validating diagnostic models.
Funding
Funding not disclosed
Founders
Product
Problem
Many low‑income regions lack access to high‑quality pathology diagnostics, and there is a shortage of diverse, annotated pathology image data needed to train reliable AI models. This limits accurate disease detection and hampers the development of AI‑driven diagnostic tools.
Solution
Nilepath creates a SaaS platform that combines a global repository of anonymized pathology images with AI tools for data annotation and diagnostic support. By partnering with local pathology labs, the company provides subsidized testing services, generating high‑quality imaging data while expanding access to essential diagnostics for underserved populations. The collected data are curated and made available to AI developers through a secure marketplace, accelerating the training of robust diagnostic algorithms. Ethical data handling practices ensure patient privacy while fostering research collaborations across borders. This model simultaneously improves patient care in developing countries and builds one of the world’s largest AI‑ready pathology datasets.
Target Audience
Primary customers are pathology laboratories and hospitals in low‑resource settings seeking affordable diagnostic services, and AI research teams or companies requiring large, diverse pathology datasets for model development.
Features
- International pathology data hub aggregating anonymized, high‑resolution slide images from partner labs
- AI‑assisted annotation workflow that leverages expert pathologists and machine learning to produce labeled datasets
- SaaS marketplace allowing AI developers to license curated pathology data for model training and validation
- Subsidized pathology testing program that lowers costs for low‑income patients while generating valuable imaging data
- Built‑in data integrity and privacy controls ensuring ethical use of patient information
- Cloud‑based infrastructure for secure storage, scalable access, and integration with existing laboratory information systems